| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 8,010 | 8,015 | 11:20 | |
| 8,005 | 8,020 | 11:20 |
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 17.04. | XFRA CAPITAL ADJUSTMENT INFORMATION - 17.04.2025 | Das Instrument 52Q SE0014401121 MAGNASENSE AB EQUITY wird ex Kapitalmassnahme gehandelt am 17.04.2025 The instrument 52Q SE0014401121 MAGNASENSE AB EQUITY is traded ex capital adjustment on 17.04.2025Das... ► Artikel lesen | |
| 08.04. | EDPR launches Amazon-backed 100MW solar project | ||
| 02.04. | EDPR to auction off 90 Vestas turbines | ||
| 02.04. | Jefferies downgrades EDP Renovaveis to "hold," cuts price target to €8.70 | ||
| 02.04. | Jefferies cuts EDP Renovaveis stock rating, lowers target |
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| Do | Magnasense AB: Overview of the Rights Issue in Magnasense AB | NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, CANADA, AUSTRALIA, HONG KONG, NEW ZEALAND, SOUTH AFRICA, SOUTH KOREA, SWITZERLAND... ► Artikel lesen | |
| Di | Magnasense AB: Magnasense AB Develops Innovative Saliva Test for Gum Disease Detection | Rights Issue to Support Development of Groundbreaking Diagnostic Tool
Magnasense AB, a company specializing in rapid diagnostics, is in the process of developing a non-invasive saliva-based test designed... ► Artikel lesen | |
| Di | Magnasense AB: Magnasense AB publishes information memorandum due to upcoming rights issue of units | NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, CANADA, AUSTRALIA, HONG KONG, NEW ZEALAND, SOUTH AFRICA, SOUTH KOREA, SWITZERLAND... ► Artikel lesen | |
| 17.04. | XFRA CAPITAL ADJUSTMENT INFORMATION - 17.04.2025 | Das Instrument 52Q SE0014401121 MAGNASENSE AB EQUITY wird ex Kapitalmassnahme gehandelt am 17.04.2025 The instrument 52Q SE0014401121 MAGNASENSE AB EQUITY is traded ex capital adjustment on 17.04.2025Das... ► Artikel lesen | |
| 10.04. | Magnasense AB: Magnasense resolves on the previously announced rights issue of units of a minimum of approx. MSEK 15 and a maximum of approx. MSEK 26.7 to develop saliva-based diagnostics as an alternative to blood testing | NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, CANADA, AUSTRALIA, HONG KONG, NEW ZEALAND, SOUTH AFRICA, SOUTH KOREA, SWITZERLAND... ► Artikel lesen |
| Unternehmen / Aktien | Kurs | % |
|---|---|---|
| EDP RENOVAVEIS SA | 7,980 | 0,00 % |
| MAGNASENSE AB | 0,018 | 0,00 % |
